Edwards Lifesciences wins FDA approval for SAPIEN M3, the first transseptal TMVR, expanding minimally invasive options for high-risk mitral regurgitation patients.
A. O. Smith Corporation is rated a Buy with risk/reward attractive as growth and margins are set to accelerate from FY26.
According to the Kentucky Transportation Cabinet, the extended closure of the I-65 South ramp to I-64 West is due to ...
The US Food and Drug Administration has approved the Sapien M3 system for transseptal transcatheter mitral valve replacement (TMVR) for use in patients with symptomatic moderate-to-severe mitral ...
The advent of transcatheter mitral valve repair (TMVr) and replacement (TMVR) has marked a revolutionary shift in the management of mitral valve disease, ...
Gov. Phil Murphy approved revisions to the Turnpike extension plan, eliminating new lanes and saving $500M while easing port ...
Future Green Irrigation, a Calgary-based irrigation contractor known for structured service processes and certified technical expertise, announced the expansion of its full irrigation services ...
Transcatheter heart valve repair and replacement have reshaped how structural heart disease is treated, and the market is ...
Abstract: Currently, cross-scene hyperspectral image (HSI) classification has drawn increasing attention. It is necessary to train a model only on source domain (SD) and directly transferring the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback